Results 221 to 230 of about 148,552 (285)

In vitro and in vivo evaluation of the leishmanicidal and cytotoxic activities of chitosan and chitosan-amphotericin B. [PDF]

AMB Express
Mousavi P, Rahimi Esboei B, Pourhajibagher M, Zolfaghari A, Shahmoradi Z, Namdar F, Ahmadi S, Mousavi SM, Parandin F, Hejazi SH.   +9 more
europepmc   +1 more source

Amphotericin B-resistant Cryptococcus laurentii meningitis with pulmonary tuberculosis in a patient with pauci-immune crescentic glomerulonephritis secondary to MPO ANCA vasculitis in Nepal- a case report. [PDF]

BMC Infect Dis
Nepali R, Kayastha J.
europepmc   +1 more source

HIV protease inhibitors restore amphotericin B activity against Candida. [PDF]

PLoS One
Elgammal Y, Salama EA, Seleem MN.
europepmc   +1 more source

Acquired amphotericin B resistance attributed to a mutated <i>ERG3</i> in <i>Candidozyma auris</i>. [PDF]

Antimicrob Agents Chemother
Massic L, Doorley LA, Jones SJ, Richardson I, Siao DD, Siao L, Dykema P, Hua C, Schneider E, Cuomo CA, Rogers PD, Van Hooser S, Parker JE, Kelly SL, Hess D, Rybak JM, Pandori M.   +16 more
europepmc   +1 more source

In-hospital survival of adults with HIV-associated cryptococcal meningitis in Tanzania: A retrospective comparison of amphotericin B-based regimen and fluconazole monotherapy. [PDF]

PLoS One
Msongela M, Musiba G, Mohamed JA, Marealle AI, Kilonzi M, Mutagonda RF.   +5 more
europepmc   +1 more source

Long-Circulating Liposomes Codelivering Amphotericin B and Retinoic Acid for Cutaneous Leishmaniasis Treatment. [PDF]

ACS Omega
Santos TT, Lages EB, Ricotta TNQ, de Oliveira LG, Ramos GS, Burlot J, Abreu S, Chaminade P, Legrand FX, Tran P, Deloménie C, Vallejos VMR, Helou DG, de Almeida RM, Queiroz-Junior CM, Teobaldo GBM, de Oliveira CLP, Ferreira LAM, Aguiar MMG, Pomel S, Frézard F.   +20 more
europepmc   +1 more source

Isavuconazole-Amphotericin B and Isavuconazole-Caspofungin In Vitro Synergic Activity Against Invasive Pulmonary Aspergillosis Molds Isolates. [PDF]

Antibiotics (Basel)
Calvo M, Caruso M, Tempesta AA, Trovato L.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Amphotericin B

Applied Microbiology and Biotechnology, 2005
Invasive fungal infections are a major cause of morbidity and mortality in immunodeficient individuals (such as AIDS patients) and in transplant recipients or tumor patients undergoing immunosuppressive chemotherapy. Amphotericin B is one of the oldest, yet most efficient antimycotic agents. However, its usefulness is limited due to dose-dependent side-
Lemke, A., Kiderlen, A. F., Kayser, Oliver   +2 more
openaire   +3 more sources